Fabrazyme

Fabrazyme
Fabrazyme® (agalsidase beta) is an enzyme replacement therapy (ETR) for the treatment of Fabry disease in adult and pediatric patients (2 years and older). It supplies the enzyme that’s missing or deficient in Fabry disease. The fully functional enzyme helps clear GL-3 buildup in your cells, which helps break down the fatty substance (globotriaosylceramide) that builds up.
Fabry disease is a rare, inherited genetic disorder that affects the body’s ability to break down certain fats (glycosphingolipids).
Administration Information
Administered via intravenous infusion. Fabrazyme is given every two weeks to help ensure that the body has an ongoing supply of fully functional enzyme to clear GL-3 in certain cells of the kidney, heart, and skin.
Potential Side Effects
The most common side effects of Fabrazyme treated patients in clinical studies compared to placebo were upper respiratory tract infection, chills, fever, headache, cough, burning and/or tingling sensation, fatigue, swelling in the legs, dizziness, and rash.
Please see full Prescribing Information on the manufacturer's website.
Before you attend your first appointment at Sage Infusion, please make sure to review the documents below. The Patient Consent Form and HIPAA Privacy Authorization Form need to be filled out and signed ahead of your appointment, whereas the Notice of Privacy Practices, Patient Rights and Responsibilities, and Appointment Lateness and Cancelation are for reference only. Please contact us if you have any questions!
Patient Consent Form
HIPAA Privacy Authorization Form
Notice of Privacy Practices
Patient Rights and Responsibilities
Appointment Lateness and Cancelation
Find a Sage Infusion Location Near You
We offer expert infusion therapy without the hassle or cost of the hospital. We employ highly trained medical staff that work with health insurance companies & physicians to provide our patients with convenient care.
SEARCH BY ZIP
Southwest Florida
Tampa Bay
